SUPRELORIN 4.7 MG IMPLANT DIN 02526689
Health Canada record
| Active ingredient(s) | DESLORELIN (DESLORELIN ACETATE) 4.7 MG |
|---|---|
| Dosage form | Implant |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 02-Aug-2023 |
| Current status date | 18-Mar-2025 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DESLORELIN (DESLORELIN ACETATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02426404 | SUCROMATE EQUINE | DECHRA REGULATORY BV | Suspension | DESLORELIN (DESLORELIN ACETATE) 1.7 MG | Approved |
| 02159708 | OVUPLANT | PEPTECH ANIMAL HEALTH PTY LTD. | Implant | DESLORELIN (DESLORELIN ACETATE) 2.1 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35023 | 2025-03-18 | Supplement to a New Drug Submission (SNDS) | Addition of indication; Addition of species |
| 30001 | 2023-01-30 | Supplement to a New Drug Submission (SNDS) | CHANGE IN THE DRUG PRODUCT MANUFACTURING PROCESS |
| 27995 | 2022-04-21 | New Drug Submission (NDS) |